Remove 2026 Remove Healthcare Remove Networking
article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. Oak Street has 169 locations across 21 states and expects to nearly double its size to 300 centers by 2026.

article thumbnail

Leaders from Boston Children’s Hospital, Google Cloud, MedCity News, Edgilty Inc, and Clarify Health discuss the future of AI in healthcare

Clarify Health

Artificial intelligence (AI) has the potential to affect healthcare in profound ways — propelling better data-driven decisions on diagnoses, treatments, and population health management. health system realize $150 billion in savings by 2026. Reports indicate that AI can help the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

EU regulators release new workplan for accelerating clinical research

European Pharmaceutical Review

The 2022-2026 workplan of the initiative Accelerating Clinical Trials in the EU ( ACT EU ) has been published by the European Commission (EC), Heads of Medicines Agencies (HMA) and European Medicines Agency (EMA). implementing the CTR – focus on CTIS and CTR training activities and trouble-shooting any issues encountered by trial sponsors.

Medicine 105
article thumbnail

EMA publishes mid-point regulatory science strategy report

European Pharmaceutical Review

Thus, regulators needed to be ready to support the development and assessment of ever more complex medicines that increasingly deliver healthcare solutions by converging different technologies. A final report on the regulatory science strategy will be published in 2026, once the strategy has been completed.

article thumbnail

CPHI Pharma Awards 2023 finalists announced

European Pharmaceutical Review

Award winners will be revealed at a networking reception on the first day of CPHI Barcelona 2023, which is running from 24-26 October. Revolutionising microencapsulation with in-air microfluidics technology for next-generation sustainable healthcare solutions. .: Are you coming to the CPHI Barcelona 2023?

Pharma 119
article thumbnail

Leaders from Boston Children’s Hospital, Google Cloud, MedCity News, Edgilty Inc, and Clarify Health discuss the future of AI in healthcare

Clarify Health

Artificial intelligence (AI) has the potential to affect healthcare in profound ways — propelling better data-driven decisions on diagnoses, treatments, and population health management. health system realize $150 billion in savings by 2026. During the panel, Dr. Ramadoss gave examples of AI applications in healthcare.

article thumbnail

Key Developments from AMCP 2023 on Blockbuster Generics, Diabetes Drugs, PBM Legislation, and More

PM360

Starting in 2026, the provision will affect 10 Part D drugs. This increases to 15 Part D drugs in 2026, as well as 15 Part B and D drugs in 2028, and a full 20 Part B and D drugs in 2029. Still, the law may impact claim operations and network contracts, Casberg noted.